Thomas Doyle's most recent trade in Kura Oncology Inc was a trade of 2,241 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Jan. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 2,241 | 90,901 (0%) | 0% | 7.9 | 17,641 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 1,122 | 88,193 (0%) | 0% | 7.9 | 8,832 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 887 | 90,014 (0%) | 0% | 7.9 | 6,982 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 699 | 89,315 (0%) | 0% | 7.9 | 5,502 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 42,500 | 42,500 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 21,250 | 71,892 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 21,250 | 93,142 (0%) | 0% | 0 | Common Stock | |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 16 Dec 2024 | 219 | 16,571 | - | 2.1 | 462 | Common Stock |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. | 16 Dec 2024 | 87 | 16,484 | - | 2.1 | 187 | Common Stock |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.65 per share. | 16 Sep 2024 | 219 | 16,877 | - | 1.6 | 361 | Common Stock |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 16 Sep 2024 | 87 | 16,790 | - | 1.7 | 144 | Common Stock |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 17 Jun 2024 | 211 | 17,180 | - | 1.9 | 403 | Common Stock |
| Heliogen Inc - Warrants (3... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share. | 17 Jun 2024 | 84 | 17,096 | - | 2.0 | 165 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.36 per share. | 15 Mar 2024 | 267 | 17,497 | - | 1.4 | 363 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 15 Mar 2024 | 106 | 17,391 | - | 1.5 | 154 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 963 | 48,093 (0%) | 0% | 17.8 | 17,142 | Common Stock |
| Kura Oncology Inc | Doyle Thomas | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 761 | 49,056 (0%) | 0% | 17.8 | 13,546 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 594 | 49,817 (0%) | 0% | 17.8 | 10,573 | Common Stock |
| Kura Oncology Inc | Doyle Thomas | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 42,500 | 42,500 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Doyle Thomas | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 21,250 | 50,411 (0%) | 0% | 0 | Common Stock | |
| Heliogen Inc - Ordinary Sh... | Doyle Thomas | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 15 Dec 2023 | 438 | 17,938 | - | 1.9 | 823 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Doyle Thomas | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.07 per share. | 15 Dec 2023 | 174 | 17,764 | - | 2.1 | 360 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.23 per share. | 20 Jun 2023 | 10,302 | 643,183 | - | 0.2 | 2,409 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 200,000 | 653,485 | - | 0 | Common Stock | |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.21 per share. | 15 Mar 2023 | 39,461 | 463,860 | - | 0.2 | 8,212 | Common Stock |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.20 per share. | 15 Mar 2023 | 10,375 | 453,485 | - | 0.2 | 2,100 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 63,750 | 63,750 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 10,625 | 27,466 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 866 | 16,841 (0%) | 0% | 13.9 | 12,029 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 682 | 17,707 (0%) | 0% | 13.9 | 9,473 | Common Stock |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 39,281 | 39,281 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Thomas Doyle | SVP, Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 8,390 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 1,006,642 | 1,006,642 | - | - | Employee Stock Option (right to buy) | |
| Heliogen Inc - Ordinary Sh... | Thomas Doyle | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 503,321 | 503,321 | - | 0 | Common Stock |